Suchergebnisse - "Jain, Rakesh"

PubPharm (1.454)

21

Evidence for the natural infection of cucurbit chlorotic yellows virus (CCYV) in lettuce plants from India

enthalten in: Indian journal of virology | 2023

von Kumar, A. | Choudhary, S. | Lyngdoh, Y. | +3

22

Tofacitinib Efficacy in Patients with Rheumatoid Arthritis and Probable Depression/Anxiety: Post Hoc Analysis of Phase 3 and 3b/4 Randomized Controlled Trials

enthalten in: Rheumatology and therapy | 2023

von Citera, G. | Jain, R. | Irazoque, F. | +7

23

Desmoplasia in cervical cancer is associated with a more aggressive tumor phenotype

enthalten in: Scientific reports | 2023

von Wolf, B. | Weydandt, L. | Dornhöfer, N. | +6

24

Losartan rewires ovarian cancer tumor-immune microenvironment and suppresses IGF-1 to amplify chemo-immunotherapy sensitivity

enthalten in: bioRxiv.org | 2023

von Sun, Y. | Yin, Z. | Wu, L. | +9

25

Treatment patterns, health care resource utilization, and costs associated with use of atypical antipsychotics as first vs subsequent adjunctive treatment in major depressive disorder

enthalten in: Journal of managed care & specialty pharmacy | 2023

von Jain, R. | Laliberté, F. | Germain, G. | +4

26

Shortwave Infrared Fluorescence Imaging with the Clinically Approved Near-Infrared Dye Indocyanine Green

enthalten in: bioRxiv.org | 2023

von Carr, J. | Franke, D. | Caram, J. | +7

27

Isoxazolyl-carbonyloxy azabicyclo[3.2.1]octanyl compounds as FXR activators

enthalten in: Europäisches Patentamt | 2023

von CHAO JIANHUA | JAIN RAKESH | HU LILY | +3

28

Multicenter, prospective, phase II study of maintenance bevacizumab for children and adults with NF2-related schwannomatosis and progressive vestibular schwannoma

enthalten in: Neuro-oncology | 2023

von Plotkin, S. | Allen, J. | Dhall, G. | +12

29

In silico clinical studies for the design of optimal COVID-19 vaccination schedules in patients with cancer

enthalten in: ResearchSquare.com | 2023

von Jain, R. | Voutouri, C. | Hardin, C. | +6

30

Computational simulations of tumor growth and treatment response : Benefits of high-frequency, low-dose drug regimens and concurrent vascular normalization

enthalten in: PLoS computational biology | 2023

von Nikmaneshi, M. | Jain, R. | Munn, L.